CHK1-driven histone H3.3 serine 31 phosphorylation is important for chromatin maintenance and cell survival in human ALT cancer cells

Nucleic Acids Research

Volumn 43, Issue 5, 2015, Pages 2603-2614

  Chang, Fiona T M ^a   Chan, F Lyn ^a   McGhie, James D R ^a   Udugama, Maheshi ^a   Mayne, Lynne ^a   Collas, Philippe ^b   Mann, Jeffrey R ^c   Wong, Lee H ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF OSLO   (Norway)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATRX PROTEIN; CHECKPOINT KINASE 1; DAXX PROTEIN; HISTONE H2AX; HISTONE H3; PROTEIN; REPETITIVE DNA; SATELLITE DNA; SERINE; UNCLASSIFIED DRUG; ATRX PROTEIN, HUMAN; CHROMATIN; DNA HELICASE; H2AFX PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; PROTEIN KINASE;

ALTENATIVE LENGTHENING OF TELOMERE; ARTICLE; CANCER CELL; CELL SURVIVAL; CELL VIABILITY; CHROMATIN; CHROMOSOME; CONTROLLED STUDY; DNA RECOMBINATION; ENZYME ACTIVITY; HETEROCHROMATIN; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN GENOME; MITOSIS; MUTATION RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SOMATIC CELL; CHROMATIN ASSEMBLY AND DISASSEMBLY; FLUORESCENCE MICROSCOPY; GENETICS; HELA CELL LINE; HT 29 CELL LINE; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TELOMERE; TRANSFORMED CELL LINE; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; HELA CELLS; HISTONES; HT29 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERINE; TELOMERE;

EID: 84937605962     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv104     Document Type: Article

References (43)

1. de Lange, T. (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev., 19, 2100-2110.
2. Zakian, V. A. (2012) Telomeres: the beginnings and ends of eukaryotic chromosomes. Exp. Cell Res., 318, 1456-1460.
3. Conomos, D., Pickett, H. A. and Reddel, R. R. (2013) Alternative lengthening of telomeres: remodeling the telomere architecture. Front. Oncol., 3, 27.
4. Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. and Reddel, R. R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med., 3, 1271-1274.
5. Henson, J. D., Cao, Y., Huschtscha, L. I., Chang, A. C., Au, A. Y. M., Pickett, H. A. and Reddel, R. R. (2009) DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat. Biotech., 27, 1181-1185.
6. Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H., Sung, P. A., Jasin, M. et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet., 8, e1002772.
7. Gagos, S., Chiourea, M., Christodoulidou, A., Apostolou, E., Raftopoulou, C., Deustch, S., Jefford, C.-E., Irminger-Finger, I., Shay, J. W. and Antonarakis, S. E. (2008) Pericentromeric instability and spontaneous emergence of human neoacrocentric and minute chromosomes in the alternative pathway of telomere lengthening. Cancer Res., 68, 8146-8155.
8. Bower, K., Napier, C. E., Cole, S. L., Dagg, R. A., Lau, L. M., Duncan, E. L., Moy, E. L. and Reddel, R. R. (2012) Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of alternative lengthening of telomeres. PLoS One, 7, e50062.
9. Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A. et al. (2010) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science, 331, 1199-1203.
10. Nguyen, D. N., Heaphy, C. M., de Wilde, R. F., Orr, B. A., Odia, Y., Eberhart, C. G., Meeker, A. K. and Rodriguez, F. J. (2013) Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol., 23, 237-243.
11. Kannan, K., Inagaki, A., Silber, J., Gorovets, D., Zhang, J., Kastenhuber, E. R., Heguy, A., Petrini, J. H., Chan, T. A. and Huse, J. T. (2012) Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget, 3, 1194-1203.
12. Schwartzentruber, J., Korshunov, A., Liu, X. Y., Jones, D. T., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D. A., Tonjes, M. et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482, 226-231.
13. Wong, L. H., McGhie, J. D., Sim, M., Anderson, M. A., Ahn, S., Hannan, R. D., George, A. J., Morgan, K. A., Mann, J. R. and Choo, K. H. (2010) ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res., 20, 351-360.
14. Wong, L. H., Ren, H., Williams, E., McGhie, J., Ahn, S., Sim, M., Tam, A., Earle, E., Anderson, M. A., Mann, J. et al. (2009) Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res., 19, 404-414.
15. Chang, F. T., McGhie, J. D., Chan, F. L., Tang, M. C., Anderson, M. A., Mann, J. R., Andy Choo, K. H. and Wong, L. H. (2013) PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells. Nucleic Acids Res., 41, 4447-4458.
16. Law, M. J., Lower, K. M., Voon, H. P., Hughes, J. R., Garrick, D., Viprakasit, V., Mitson, M., De Gobbi, M., Marra, M., Morris, A. et al. (2010) ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell, 143, 367-378.
17. Goldberg, A. D., Banaszynski, L. A., Noh, K. M., Lewis, P. W., Elsaesser, S. J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X. et al. (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell, 140, 678-691.
18. Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C. and Allis, C. D. (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl Acad. Sci. U. S. A., 107, 14075-14080.
19. Drane, P., Ouararhni, K., Depaux, A., Shuaib, M. and Hamiche, A. (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev., 24, 1253-1265.
20. Wong, L. H. (2010) Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells. Epigenomics, 2, 639-655.
21. Eustermann, S., Yang, J. C., Law, M. J., Amos, R., Chapman, L. M., Jelinska, C., Garrick, D., Clynes, D., Gibbons, R. J., Rhodes, D. et al. (2011) Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat. Struct. Mol. Biol., 18, 777-782.
22. Iwase, S., Xiang, B., Ghosh, S., Ren, T., Lewis, P. W., Cochrane, J. C., Allis, C. D., Picketts, D. J., Patel, D. J., Li, H. et al. (2011) ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat. Struct. Mol. Biol., 18, 769-776.
23. Clynes, D. and Gibbons, R. J. (2013) ATRX and the replication of structured DNA. Curr. Opin. Genet. Dev., 23, 289-294.
24. Clynes, D., Higgs, D. R. and Gibbons, R. J. (2013) The chromatin remodeller ATRX: a repeat offender in human disease. Trends Biochem. Sci., 38, 461-466.
25. Giraud-Panis, M. J., Pisano, S., Benarroch-Popivker, D., Pei, B., Le Du, M. H. and Gilson, E. (2013) One identity or more for telomeres? Front. Oncol., 3, 48.
26. Huh, M. S., Price O'Dea, T., Ouazia, D., McKay, B. C., Parise, G., Parks, R. J., Rudnicki, M. A. and Picketts, D. J. (2012) Compromised genomic integrity impedes muscle growth after Atrx inactivation. J. Clin. Invest., 122, 4412-4423.
27. Watson, L. A., Solomon, L. A., Li, J. R., Jiang, Y., Edwards, M., Shin-ya, K., Beier, F. and Berube, N. G. (2013) Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. J. Clin. Invest., 123, 2049-2063.
28. Leung, J. W.-C., Ghosal, G., Wang, W., Shen, X., Wang, J., Li, L. and Chen, J. (2013) Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress. J. Biol. Chem., 288, 6342-6350.
29. Hake, S. B., Garcia, B. A., Kauer, M., Baker, S. P., Shabanowitz, J., Hunt, D. F. and Allis, C. D. (2005) Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc. Natl Acad. Sci. U. S. A., 102, 6344-6349.
30. Shimada, M., Niida, H., Zineldeen, D. H., Tagami, H., Tanaka, M., Saito, H. and Nakanishi, M. (2008) Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell, 132, 221-232.
31. Liokatis, S., Stutzer, A., Elsasser, S. J., Theillet, F. X., Klingberg, R., van Rossum, B., Schwarzer, D., Allis, C. D., Fischle, W. and Selenko, P. (2012) Phosphorylation of histone H3 Ser10 establishes a hierarchy for subsequent intramolecular modification events. Nat. Struct. Mol. Biol., 19, 819-823.
32. Wong, L. H., Saffery, R., Anderson, M. A., Earle, E., Quach, J. M., Stafford, A. J., Fowler, K. J. and Choo, K. H. (2005) Analysis of mitotic and expression properties of human neocentromere-based transchromosomes in mice. J. Biol. Chem., 280, 3954-3962.
33. Thompson, R., Montano, R. and Eastman, A. (2012) The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition. PLoS One, 7, e44021.
34. Chan, F. L., Marshall, O. J., Saffery, R., Kim, B. W., Earle, E., Choo, K. H. and Wong, L. H. (2012) Active transcription and essential role of RNA polymerase II at the centromere during mitosis. Proc. Natl Acad. Sci. U. S. A., 109, 1979-1984.
35. Wong, L. H., Brettingham-Moore, K. H., Chan, L., Quach, J. M., Anderson, M. A., Northrop, E. L., Hannan, R., Saffery, R., Shaw, M. L., Williams, E. et al. (2007) Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Res., 17, 1146-1160.
36. Jackson, J. R., Gilmartin, A., Imburgia, C., Winkler, J. D., Marshall, L. A. and Roshak, A. (2000) An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res., 60, 566-572.
37. O'Sullivan, R. J., Arnoult, N., Lackner, D. H., Oganesian, L., Haggblom, C., Corpet, A., Almouzni, G. and Karlseder, J. (2014) Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat. Struct. Mol. Biol., 21, 167-174.
38. Vassilev, L. T., Tovar, C., Chen, S., Knezevic, D., Zhao, X., Sun, H., Heimbrook, D. C. and Chen, L. (2006) Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl Acad. Sci. U. S. A., 103, 10660-10665.
39. Sawicka, A. and Seiser, C. (2012) Histone H3 phosphorylation - a versatile chromatin modification for different occasions. Biochimie, 94, 2193-2201.
40. Metzger, E., Yin, N., Wissmann, M., Kunowska, N., Fischer, K., Friedrichs, N., Patnaik, D., Higgins, J. M., Potier, N., Scheidtmann, K. H. et al. (2008) Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat. Cell Biol., 10, 53-60.
41. Frey, A., Listovsky, T., Guilbaud, G., Sarkies, P. and Sale, J. E. (2014) Histone H3.3 is required to maintain replication fork progression after UV damage. Curr. Biol., 24, 2195-2201.
42. Orthwein, A., Fradet-Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano-Diaz, C. and Durocher, D. (2014) Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science, 344, 189-193.
43. McNeely, S., Beckmann, R. and Bence Lin, A. K. (2014) CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy. Pharmacol. Ther., 142, 1-10.